ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
78 hedge funds and large institutions have $18.6M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
68% less call options, than puts
Call options by funds: $60K | Put options by funds: $189K
Holders
78
Holding in Top 10
–
Calls
$60K
Puts
$189K
Top Buyers
| 1 | +$585K | |
| 2 | +$267K | |
| 3 | +$233K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$140K |
| 5 |
Two Sigma Advisers
New York
|
+$118K |
Top Sellers
| 1 | -$657K | |
| 2 | -$240K | |
| 3 | -$188K | |
| 4 |
Morgan Stanley
New York
|
-$171K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$134K |